1 Min Read
May 1 (Reuters) - Sanofi Sa
* Sanofi genzyme announces approval of cerdelga (eliglustat capsules) by health canada for rare genetic condition Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.